Stefano Doccini Selected Research

Antioxidants

7/2022	In vitro study of polydopamine nanoparticles as protective antioxidant agents in fibroblasts derived from ARSACS patients.
6/2020	Development of Nanostructured Lipid Carriers for the Delivery of Idebenone in Autosomal Recessive Spastic Ataxia of Charlevoix-Saguenay.
11/2019	The Extra-Virgin Olive Oil Polyphenols Oleocanthal and Oleacein Counteract Inflammation-Related Gene and miRNA Expression in Adipocytes by Attenuating NF-κB Activation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Stefano Doccini Research Topics

Disease

6	Mitochondrial Diseases (Mitochondrial Disease) 02/2023 - 01/2020
5	Spastic ataxia Charlevoix-Saguenay type 07/2022 - 01/2020
2	Disease Progression 05/2024 - 08/2021
2	Brain Diseases (Brain Disorder) 11/2023 - 01/2023
2	Nervous System Diseases (Neurological Disorders) 02/2023 - 01/2023
2	Inflammation (Inflammations) 01/2023 - 11/2019
2	Neoplasms (Cancer) 01/2023 - 08/2020
2	Necrosis 07/2022 - 08/2020
2	Neuronal Ceroid-Lipofuscinoses (Neuronal Ceroid Lipofuscinosis) 01/2022 - 01/2020
2	Seizures (Absence Seizure) 12/2019 - 01/2014
1	Hereditary Spastic Paraplegia 02/2023
1	Pyruvate Dehydrogenase Complex Deficiency Disease 01/2023
1	Obesity 01/2023
1	Polyneuropathies (Polyneuropathy) 01/2023
1	Neuromuscular Diseases (Neuromuscular Disease) 11/2022
1	Spinocerebellar Degenerations (Marinesco Sjogren Syndrome) 08/2021
1	Atrophy 08/2021
1	Melanoma (Melanoma, Malignant) 08/2020
1	Spastic Ataxia 01/2020
1	Charcot-Marie-Tooth Disease (Peroneal Muscular Atrophy) 01/2020
1	Spinocerebellar Ataxias (Spinocerebellar Ataxia) 01/2020
1	Usher Syndromes (Usher Syndrome) 01/2020
1	Epilepsy (Aura) 12/2019
1	Epilepsia Partialis Continua 12/2019
1	Ischemia 01/2018
1	Muscular Dystrophies (Muscular Dystrophy) 12/2016
1	Intellectual Disability (Idiocy) 01/2014

Drug/Important Bio-Agent (IBA)

10	Proteins (Proteins, Gene)FDA Link 11/2023 - 01/2020
4	MicroRNAs (MicroRNA)IBA 01/2023 - 01/2018
3	AntioxidantsIBA 07/2022 - 11/2019
2	Reactive Oxygen Species (Oxygen Radicals)IBA 02/2023 - 08/2021
2	idebenoneIBA 07/2022 - 06/2020
2	Biomarkers (Surrogate Marker)IBA 01/2020 - 01/2020
2	Amino Acids FDA Link 01/2020 - 01/2014
2	EnzymesIBA 01/2020 - 11/2019
1	TrehaloseIBA 05/2024
1	Pyruvate Dehydrogenase Complex (Dehydrogenase Complex, Pyruvate)IBA 01/2023
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2023
1	Chemokine CCL5IBA 01/2023
1	ChemokinesIBA 01/2023
1	tanshinoneIBA 01/2023
1	Plasminogen Activator Inhibitor 1IBA 01/2023
1	Cerebrospinal Fluid ProteinsIBA 01/2023
1	cryptotanshinoneIBA 01/2023
1	CytokinesIBA 01/2023
1	CollagenIBA 11/2022
1	ResveratrolIBA 07/2022
1	polydopamineIBA 07/2022
1	phenyl di-n-pentylphosphinateIBA 07/2022
1	Mitochondrial DNA (mtDNA)IBA 07/2021
1	ProteomeIBA 07/2021
1	LuciferasesIBA 08/2020
1	Adenosine Triphosphate (ATP)IBA 06/2020
1	LipidsIBA 06/2020
1	Adenosine Triphosphatases (ATPase)IBA 01/2020
1	Histidine (L-Histidine)FDA Link 01/2020
1	Histidine-tRNA LigaseIBA 01/2020
1	Transfer RNA (tRNA)IBA 01/2020
1	Adrenal Cortex Hormones (Corticosteroids)IBA 12/2019
1	Immunoglobulins (Immunoglobulin)IBA 12/2019
1	Matrix Metalloproteinases (MMPs)IBA 11/2019
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 11/2019
1	Olive OilIBA 11/2019
1	oleaceinIBA 11/2019
1	oleocanthalIBA 11/2019
1	PolyphenolsIBA 11/2019
1	NADPH Oxidases (NAD(P)H oxidase)IBA 11/2019
1	Triiodothyronine (Liothyronine)FDA LinkGeneric 01/2018
1	3- (3,5- dichlorophenyl)- 1- methyl- 2,5- pyrrolidinedione (DPMS)IBA 12/2016
1	dolichyl-phosphate beta-D-mannosyltransferaseIBA 12/2016
1	Dystroglycans (Dystroglycan)IBA 12/2016
1	aminoacylase I (aminoacylase)IBA 01/2014

Therapy/Procedure

2	Therapeutics 08/2021 - 06/2020